Trial intelligence / Profile preview

PBMC plus platelet-rich plasma for vesicoureteral reflux in children

IRCT20190117042391N1Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
Feb 2019
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of platelet-rich plasma in vesicoureteral reflux (VUR), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Status and grade of reflux. Started Feb 2019; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

vesicoureteral reflux (VUR)

Beyond the preview

Go deeper on IRCT20190117042391N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190117042391N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call